Image of a patient inside of a scanner.

Medical Residency Program

Welcome from the Program Director

Photograph of Dr. CooperWelcome and thank you for your interest in the Medical University of South Carolina Radiation Oncology residency program. Our mission is to develop future radiation oncologists that deliver excellent, evidence-based, and compassionate care. We strive to instill a thirst for knowledge and an ongoing quest for career-long continuous learning and self-improvement, through integration of didactic teaching, clinical research, quality improvement, and clinical care into the educational process.

The Hollings Cancer Center at the Medical University of South Carolina is the only NCI-designated cancer center in the state of South Carolina. Residents are exposed to a diverse patient population and have broad training in brachytherapy, radiosurgery, image-guided radiotherapy, unsealed sources, and total body irradiation. In addition, resident training is complemented by a didactic program with protected time each week for physics, radiobiology, as well as clinical didactics that cover all disease sites each year. Residents are given 9 months of elective time during their residency to pursue research or other clinical interests. Finally, residents are given financial support to present their research at national meetings.

Our graduates work in a variety of academic and private practice settings around the country and remain close after graduation. Please take time to explore our website to learn more about the Medical University of South Carolina and our training program. We greatly appreciate your interest in our program.

Samuel L. Cooper, M.D.
Program Director, Radiation Oncology Residency Program


Established in 1824 as one of the nation’s first medical schools, the Medical University of South Carolina (MUSC) provides the most up to date care and biomedical research available in South Carolina and the Southeast. In an era of shrinking research dollars, the University has increased its research funds dramatically over the last decade, placing it in the upper tiers of medical schools in terms of research dollars with over $247 million in research funds in 2015.

The Hollings Cancer Center (HCC) at MUSC is among fewer than 70 cancer centers that have achieved recognition as a National Cancer Institute designated Cancer Center. It hosts the MUSC Department of Radiation Oncology in the main HCC building, with over 200,000 square feet of multidisciplinary clinics, research laboratories, conference facilities, and more. Core facilities include biostatistics support, flow cytometry and cell sorting, cell and molecular imaging, small animal imaging, tissue biorepository, gene targeting and knockout, lipidomics synthesis and analysis, cellular therapy, drug discovery and screening, and clinical trials support. HCC has over $43 million in research funding. Research programs include Cancer Immunology, Cancer Genes & Molecular Regulation, Developmental Cancer Therapeutics, and Cancer Control. U.S. News and World Report ranks the Hollings Cancer Center in the top 50 cancer centers in the U.S. for 2015 to 2016.